Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 26, 2018 10:50 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Reports Successful Close-Out of its April 2018 FDA Compliance Inspection

RAMSEY, N.J. and BOCA RATON, Fla., July 26, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical company that...
July 26, 2018 07:58 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Receives PDUFA Date for BIVIGAM® Regulatory Submission

Prior Approval Supplement (“PAS”) to Amend the Biologics License Application (“BLA”) for BIVIGAM® is Supported by Data and Documentation Prepared Using ADMA’s Optimized IVIG Manufacturing Process...
June 25, 2018 07:08 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Added to the Russell 3000 and Russell 2000 Indexes

RAMSEY, N.J. and BOCA RATON, Fla., June 25, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a vertically integrated commercial biopharmaceutical company that manufactures, markets and...
June 12, 2018 16:05 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Announces Closing of $40M Public Offering

RAMSEY, N.J. and BOCA RATON, Fla., June 12, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) (“ADMA” or the “Company”) announced today the closing of its previously announced underwritten...
June 08, 2018 09:08 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Announces Pricing of Public Offering of Common Stock

RAMSEY, N.J. and BOCA RATON, Fla., June 08, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) (“ADMA” or the “Company”) announced today the pricing of its previously announced underwritten...
June 07, 2018 16:05 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Announces Proposed Public Offering of Common Stock

RAMSEY, N.J. and BOCA RATON, Fla., June 07, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) (“ADMA” or the “Company”) announced today that it has commenced an underwritten public...
May 16, 2018 07:30 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Granted U.S. Patent for Treating Respiratory Infections

RAMSEY, N.J. and BOCA RATON, Fla., May 16, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) (“ADMA” or the “Company”) today announced that the United States Patent and Trademark Office...
May 14, 2018 17:05 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Reports First Quarter 2018 Financial Results

RAMSEY, N.J. and BOCA RATON, Fla., May 14, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) (“ADMA” or the “Company”), today announced its financial results for the quarter ended March...
May 14, 2018 13:17 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Retires Approximately 8.6 Million Shares Previously Issued to Biotest

RAMSEY, N.J. and BOCA RATON, Fla., May 14, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) (“ADMA” or the “Company”) announced today that it has negotiated the receipt and immediate...
April 24, 2018 07:28 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Announces the Release of its First Commercial Batch of Nabi-HB Manufactured Under its Ownership

RAMSEY, N.J. and BOCA RATON, Fla., April 24, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) (“ADMA” or the “Company”), today announced that it has successfully completed the...